These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 15595218)

  • 1. Enterprising pharmacists use Medicare card to lower costs for health system, patients.
    Young D
    Am J Health Syst Pharm; 2004 Dec; 61(23):2462, 2465-6, 2472. PubMed ID: 15595218
    [No Abstract]   [Full Text] [Related]  

  • 2. States on the Front Line: Addressing America's Drug Pricing Problem.
    Riley T; Lanford S
    J Leg Med; 2019; 39(2):81-93. PubMed ID: 31503529
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicare prescription drug legislation: how would it affect beneficiaries?
    Moon M
    Policy Brief Commonw Fund; 2003 Oct; (678):1-12. PubMed ID: 14524369
    [No Abstract]   [Full Text] [Related]  

  • 4. Public payers foot greater pharmacy costs.
    Manag Care; 2006 Jul; 15(7):70. PubMed ID: 16898070
    [No Abstract]   [Full Text] [Related]  

  • 5. Where are we, how did we get here, where are we going?
    Davis K
    Med Care; 1995 Jan; 33(1 Suppl):JS3-7; discussion JS7-12. PubMed ID: 7823655
    [No Abstract]   [Full Text] [Related]  

  • 6. State model: Washington. Managed competition and premium caps in Washington State.
    Crittenden RA
    Health Aff (Millwood); 1993; 12(2):82-8. PubMed ID: 8375827
    [No Abstract]   [Full Text] [Related]  

  • 7. Redefining Medicare's long-term financial health: a closer look at the "Medicare funding warning" in the trustees' report.
    Caplan C; Housman L
    Issue Brief (Public Policy Inst (Am Assoc Retired Pers)); 2004 Jun; (IB67):1-4. PubMed ID: 15254986
    [No Abstract]   [Full Text] [Related]  

  • 8. Affordable prescription drugs for NC consumers: the next challenge.
    Savage HH
    N C Med J; 2003; 64(6):298-9. PubMed ID: 14983624
    [No Abstract]   [Full Text] [Related]  

  • 9. AMCP Guide to Pharmaceutical Payment Methods.
    AMCP Task Force on Drug Payment Methodologies
    J Manag Care Pharm; 2007 Oct; 13(8 Suppl C):S1-39. PubMed ID: 17970611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selling cost containment.
    Jost TS; Tanenbaum SJ
    Am J Law Med; 1993; 19(1-2):95-119. PubMed ID: 8368204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specialty pharmacy management adjusts to new financial realities.
    Reinke T
    Manag Care; 2013 Apr; 22(4):13-4. PubMed ID: 23678558
    [No Abstract]   [Full Text] [Related]  

  • 12. State model: Vermont. Health care reform in Vermont: a work in progress.
    Leichter HM
    Health Aff (Millwood); 1993; 12(2):71-81. PubMed ID: 8375826
    [No Abstract]   [Full Text] [Related]  

  • 13. A time to sow: strengthening public programs.
    Kertesz L
    Healthplan; 2000; 41(3):62-4, 66-71. PubMed ID: 11066252
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of an annual dollar limit or "cap" on prescription drug benefits for Medicare patients.
    Tseng CW; Brook RH; Keeler E; Mangione CM
    JAMA; 2003 Jul; 290(2):222-7. PubMed ID: 12851277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare and Medicaid programs; limits on payments for drugs--HCFA. Final rule.
    Fed Regist; 1987 Jul; 52(147):28648-58. PubMed ID: 10301766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The state and consequences of dermatology drug prices in the United States.
    Albrecht J; Lebwohl M; Asgari MM; Bennett DD; Cook A; Evans CC; Green LJ; Hodge JA; Kourosh AS; Maloney ME; Howard LM; Olsen EA; Rosenberg SP; Rubin A; Stough DB; Taylor SC; Brod BA
    J Am Acad Dermatol; 2016 Sep; 75(3):603-605. PubMed ID: 27423978
    [No Abstract]   [Full Text] [Related]  

  • 17. Average out-of-pocket health care costs for Medicare+Choice enrollees increase substantially in 2002.
    Gold M; Achman L
    Issue Brief (Commonw Fund); 2002 Nov; (575):1-8. PubMed ID: 12425302
    [No Abstract]   [Full Text] [Related]  

  • 18. The Medicare Prescription Drug, Improvement, and Modernization Act of 2003: implications for health-system pharmacy.
    Meyer BM; Cantwell KM
    Am J Health Syst Pharm; 2004 May; 61(10):1042-51. PubMed ID: 15160781
    [No Abstract]   [Full Text] [Related]  

  • 19. Medicare reform's impact on long-term care.
    Stefanacci RG
    J Am Med Dir Assoc; 2004; 5(6):418-21. PubMed ID: 15530184
    [No Abstract]   [Full Text] [Related]  

  • 20. Consider medicare drug benefit plan for healthcare reform.
    Henschke MR
    J Am Osteopath Assoc; 2002 Oct; 102(10):523-4. PubMed ID: 12401037
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.